Results 101 to 110 of about 61,357 (186)

A case report of primary intrahepatic adeno squamous cell cholangiocarcinoma

Introduction: Hepatocellular carcinoma is the most common form of primary liver cancer. Intrahepatic cholangiocarcinoma and fibrolamellar carcinoma make up most other cases.
Fionn Woulfe (19811338), Michael Devine (16489467), Adrian O'Sullivan (19811341), Rory Crotty (12509683), Brian Hayes (112164)   +4 more
core   +2 more sources

Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma [PDF]

, 2016
Nagasaki University (長崎大学)博士(医学)Background: Intrahepatic cholangiocarcinomas develop through a multi-step carcinogenesis. Precancerous lesions are defined as biliary intraepithelial neoplasia.
松島, 肇
core  

Recap on epidemiology of cholangiocarcinoma

, 2021
Cholangiocarcinoma is a type of ...
C. La Vecchia
core  

Case report: Combinations of immune checkpoint inhibitor, chemotherapy, and hyperthermia therapy avoid lymphatic recurrence in cholangiocarcinoma

Frontiers in Oncology
Cholangiocarcinoma is a malignancy known for its aggressiveness and limited treatment options. The malignant tumor behaviors include intrahepatic recurrence, regional lymph node (LN) metastasis, peritoneal carcinomatosis, and lung metastasis.
Heng-Jui Chang, Chiao-Hsu Ke, Yu-Shan Wang, Yu-Shan Wang   +3 more
doaj   +1 more source

Outcomes of intrahepatic cholangiocarcinoma after liver resection

, 2013
BACKGROUND & AIMS: Background and aims: The optimal surgical management for intrahepatic cholangiocarcinoma (IHC) is controversial especially in regard to the need for radical lymphadenectomy.
Tsang, SHY, Chan, ACY, Chok, KSH, Poon, RTP, Wong, TCL, Cheung, TT   +5 more
core   +1 more source

Prognostic role of claudin-18.2 in intrahepatic cholangiocarcinoma

[[abstract]]Claudins are key components of tight junctions, essential for maintaining cellular adhesion, regulating intercellular molecule transport, and preserving cell polarity.
Kuo, YH;Ong, KH;Sun, DP;Tian, YF;Chou, CL;Chan, TC;Hsing, CH;Li, WS;Li, CF;Shiue, YL
core   +1 more source

Advances in Immunotherapy for Intrahepatic Cholangiocarcinoma. [PDF]

Int J Mol Sci
Qi H, Pan J, Wu H.
europepmc   +1 more source

Intrahepatic Cholangiocarcinoma: The Weight of History. [PDF]

Cureus
Costa Cabral T, Ambrósio AR, Silva BM, de Oliveira I, Pêgo H.   +4 more
europepmc   +1 more source

Does Surgical Approach Influence Benchmark Attainment in Intrahepatic Cholangiocarcinoma? [PDF]

World J Surg
Gastineau D, Goumard C, Doussot A, Allard MA, Venezia R, Langella S, Millet G, Bustamante R, Hobeika C, Rhaiem R, Tzedakis S, Jeddou H, Le Floch B, Valverde A, Peru N, Pessaux P, Giannone F, Mabrut JY, Mohkam K, Sa Cunha A, Salloum C, Blanc PY, Le Roy B, Kawai T, Farges O, Hofmeyr S, Fuks D, Truant S, Cherqui D, Ferrero A, Boleslawski E, Regimbeau JM, Vibert E, Sommacale D, Soubrane O, Scatton O, Laurent A, Brustia R, AFC‐ICC‐2009, AFC‐LLR‐2018, PRS‐2019 and FRIES‐ACHBPT‐2024 Study group.   +40 more
europepmc   +1 more source

Intrahepatic Cholangiocarcinoma [PDF]

, 2018
Marco Massani, Tommaso Stecca, Bruno Pauletti, Gianpaolo Marte, Cesare Ruffolo, Luca Bonariol, Nicolo’ Bassi   +6 more
openaire   +2 more sources